Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentazocine premedication with ketofol sedation for short gynecological procedures
IRCT20221109056455N3Phase 4Recruiting
- Sponsor
- Tata Main Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pentazocine (3 arms), sponsored by Tata Main Hospital. Primary endpoint: incidence of significant movement. Started Oct 2026; status: recruiting.
02
Drugs
pentazocine
Beyond the preview
Go deeper on IRCT20221109056455N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221109056455N3.